{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:34:01Z","timestamp":1789097641860,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s10147-025-02734-0","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T15:48:22Z","timestamp":1741362502000},"page":"1040-1047","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Questionnaire-based survey on the extent of lymph node dissection during interval debulking surgery after neoadjuvant chemotherapy for patients with advanced ovarian cancer in the Gynecologic Cancer Study Group of JCOG"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8470-4958","authenticated-orcid":false,"given":"Yuki","family":"Iida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4065-0289","authenticated-orcid":false,"given":"Mayumi","family":"Kobayashi-Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4507-6848","authenticated-orcid":false,"given":"Hiroaki","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8855-2966","authenticated-orcid":false,"given":"Mitsuya","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6929-5463","authenticated-orcid":false,"given":"Toyomi","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Gynecologic Cancer Study Group of the Japan Clinical Oncology Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"key":"2734_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263","journal-title":"CA Cancer J Clin"},{"key":"2734_CR2","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3322\/caac.21559","volume":"69","author":"S Lheureux","year":"2019","unstructured":"Lheureux S, Braunstein M, Oza AM (2019) Epithelial ovarian cancer: evolution of management in the era of precision medicine. CA Cancer J Clin 69:280\u2013304","journal-title":"CA Cancer J Clin"},{"key":"2734_CR3","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1136\/ijgc-2020-001640","volume":"30","author":"A Fagotti","year":"2020","unstructured":"Fagotti A, Ferrandina MG, Vizzielli G et al (2020) Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850). Int J Gynecol Cancer 30:1657\u20131664","journal-title":"Int J Gynecol Cancer"},{"key":"2734_CR4","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1056\/NEJMoa1808424","volume":"380","author":"P Harter","year":"2019","unstructured":"Harter P, Sehouli J, Lorusso D et al (2019) A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms. N Engl J Med 380:822\u2013832","journal-title":"N Engl J Med"},{"key":"2734_CR5","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2022.33.e69","volume":"33","author":"G Caruso","year":"2022","unstructured":"Caruso G, Palaia I, Bogani G et al (2022) Systematic lymph node dissection during interval debulking surgery for advanced epithelial ovarian cancer: a systematic review and meta-analysis. J Gynecol Oncol 33:e69","journal-title":"J Gynecol Oncol"},{"key":"2734_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/jso.24669","volume":"116","author":"KJ Eoh","year":"2017","unstructured":"Eoh KJ, Yoon JW, Lee I et al (2017) The efficacy of systematic lymph node dissection in advanced epithelial ovarian cancer during interval debulking surgery performed after neoadjuvant chemotherapy. J Surg Oncol 116:329\u2013336","journal-title":"J Surg Oncol"},{"key":"2734_CR7","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.jogc.2017.05.008","volume":"39","author":"A Kaban","year":"2017","unstructured":"Kaban A, Topuz S, Saip P et al (2017) Poor prognostic factors in patients undergoing surgery after neoadjuvant chemotherapy for ovarian, tubal, or peritoneal cancer. J Obstet Gynaecol Can 39:1163\u20131170","journal-title":"J Obstet Gynaecol Can"},{"key":"2734_CR8","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.3390\/jcm9082427","volume":"9","author":"V Bund","year":"2020","unstructured":"Bund V, Lecointre L, Velten M et al (2020) Impact of lymphadenectomy on survival of patients with serous advanced ovarian cancer after neoadjuvant chemotherapy: a French National Multicenter Study (FRANCOGYN). J Clin Med 9:2427","journal-title":"J Clin Med"},{"key":"2734_CR9","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1245\/s10434-012-2400-9","volume":"19","author":"A Fagotti","year":"2012","unstructured":"Fagotti A, De Iaco P, Fanfani F et al (2012) Systematic pelvic and aortic lymphadenectomy in advanced ovarian cancer patients at the time of interval debulking surgery: a double-institution case-control study. Ann Surg Oncol 19:3522\u20133527","journal-title":"Ann Surg Oncol"},{"key":"2734_CR10","first-page":"5503","volume":"35","author":"L Schwartz","year":"2015","unstructured":"Schwartz L, Schrot-Sanyan S, Brigand C et al (2015) Impact of pelvic and para-aortic lymphadenectomy in advanced ovarian cancer after neoadjuvant chemotherapy. Anticancer Res 35:5503\u20135509","journal-title":"Anticancer Res"},{"key":"2734_CR11","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/ijgc-2018-000200","volume":"29","author":"N Song","year":"2019","unstructured":"Song N, Gao Y (2019) Therapeutic value of selective lymphadenectomy in interval debulking surgery for stage IIIc and IV epithelial ovarian cancer. Int J Gynecol Cancer 29:761\u2013767","journal-title":"Int J Gynecol Cancer"},{"key":"2734_CR12","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.ejso.2020.04.029","volume":"46","author":"L Vincent","year":"2020","unstructured":"Vincent L, Jankowski C, Ouldamer L et al (2020) Prognostic factors of overall survival for patients with FIGO stage IIIc or IVa ovarian cancer treated with neo-adjuvant chemotherapy followed by interval debulking surgery: a multicenter cohort analysis from the FRANCOGYN study group. Eur J Surg Oncol 46:1689\u20131696","journal-title":"Eur J Surg Oncol"},{"key":"2734_CR13","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1111\/jog.14838","volume":"47","author":"A Lopes","year":"2021","unstructured":"Lopes A, Genta MLND, da Costa MV et al (2021) Role of systematic pelvic and para-aortic lymphadenectomy in delayed debulking surgery after six neoadjuvant chemotherapy cycles for high-grade serous ovarian carcinoma. J Obstet Gynaecol Res 47:2737\u20132744","journal-title":"J Obstet Gynaecol Res"},{"key":"2734_CR14","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3802\/jgo.2015.26.4.303","volume":"26","author":"H Iwase","year":"2015","unstructured":"Iwase H, Takada T, Iitsuka C et al (2015) Clinical significance of systematic retroperitoneal lymphadenectomy during interval debulking surgery in advanced ovarian cancer patients. J Gynecol Oncol 26:303\u2013310","journal-title":"J Gynecol Oncol"},{"key":"2734_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.646135","volume":"11","author":"M He","year":"2021","unstructured":"He M, Lai Y, Peng H et al (2021) Role of lymphadenectomy during interval debulking surgery performed after neoadjuvant chemotherapy in patients with advanced ovarian cancer. Front Oncol 11:646135","journal-title":"Front Oncol"},{"key":"2734_CR16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ejso.2021.10.027","volume":"48","author":"L Benoit","year":"2022","unstructured":"Benoit L, Koual M, Le Fr\u00e8re-Belda MA et al (2022) Risks and benefits of systematic lymphadenectomy during interval debulking surgery for advanced high grade serous ovarian cancer. Eur J Surg Oncol 48:275\u2013282","journal-title":"Eur J Surg Oncol"},{"key":"2734_CR17","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1136\/ijgc-2024-005291","volume":"34","author":"D Nasioudis","year":"2024","unstructured":"Nasioudis D, Gysler S, Latif NA et al (2024) Role of systematic lymphadenectomy at the time of interval debulking surgery for patients with advanced-stage epithelial ovarian carcinoma who achieved complete gross resection. Int J Gynecol Cancer 34:969\u2013974","journal-title":"Int J Gynecol Cancer"},{"key":"2734_CR18","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2021.32.e49","volume":"32","author":"H Tokunaga","year":"2021","unstructured":"Tokunaga H, Mikami M, Nagase S et al (2021) The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer. J Gynecol Oncol 32:e49","journal-title":"J Gynecol Oncol"},{"issue":"5","key":"2734_CR19","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1111\/jog.14735","volume":"47","author":"M Mayama","year":"2021","unstructured":"Mayama M, Sekine M, Onodera Y et al (2021) Attitudes toward overtime work and self-training: a survey on obstetricians and gynecologists in Japan. J Obstet Gynaecol Res 47(5):1666\u20131674","journal-title":"J Obstet Gynaecol Res"},{"key":"2734_CR20","doi-asserted-by":"publisher","first-page":"326.e1","DOI":"10.1016\/j.ajog.2019.05.006","volume":"221","author":"BL Manning-Geist","year":"2019","unstructured":"Manning-Geist BL, Hicks-Courant K, Gockley AA et al (2019) A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome. Am J Obstet Gynecol 221:326.e1\u20136.e7","journal-title":"Am J Obstet Gynecol"},{"key":"2734_CR21","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ejogrb.2017.10.019","volume":"219","author":"CKM Vermeulen","year":"2017","unstructured":"Vermeulen CKM, Tadesse W, Timmermans M et al (2017) Only complete tumour resection after neoadjuvant chemotherapy offers benefit over suboptimal debulking in advanced ovarian cancer. Eur J Obstet Gynecol Reprod Biol 219:100\u2013105","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2734_CR22","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.ygyno.2022.03.014","volume":"165","author":"H Lim","year":"2022","unstructured":"Lim H, In Shim J, Park SJ et al (2022) Impact of no residual disease on postoperative computed tomography on survival in patients with optimally debulked advanced high-grade serous ovarian cancer during upfront surgery. Gynecol Oncol 165:493\u2013499","journal-title":"Gynecol Oncol"},{"key":"2734_CR23","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.ygyno.2015.06.010","volume":"138","author":"IA Burger","year":"2015","unstructured":"Burger IA, Goldman DA, Vargas HA et al (2015) Incorporation of postoperative CT data into clinical models to predict 5-year overall and recurrence free survival after primary cytoreductive surgery for advanced ovarian cancer. Gynecol Oncol 138:554\u2013559","journal-title":"Gynecol Oncol"},{"key":"2734_CR24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1159\/000365357","volume":"87","author":"D Lorusso","year":"2014","unstructured":"Lorusso D, Sarno I, Di Donato V et al (2014) Is postoperative computed tomography evaluation a prognostic indicator in patients with optimally debulked advanced ovarian cancer? Oncology 87:293\u2013299","journal-title":"Oncology"},{"key":"2734_CR25","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2020.31.e34","volume":"31","author":"S Tate","year":"2020","unstructured":"Tate S, Nishikimi K, Kato K et al (2020) Microscopic diseases remain in initial disseminated sites after neoadjuvant chemotherapy for stage III\/IV ovarian, tubal, and primary peritoneal cancer. J Gynecol Oncol 31:e34","journal-title":"J Gynecol Oncol"},{"key":"2734_CR26","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/jog.14446","volume":"47","author":"H Komatsu","year":"2021","unstructured":"Komatsu H, Iida Y, Osaku D et al (2021) Effects of pretreatment radiological and pathological lymph node statuses on prognosis in patients with ovarian cancer who underwent interval debulking surgery with lymphadenectomy following neoadjuvant chemotherapy. J Obstet Gynaecol Res 47:152\u2013158","journal-title":"J Obstet Gynaecol Res"},{"issue":"3","key":"2734_CR27","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.ygyno.2021.06.025","volume":"162","author":"L Benoit","year":"2021","unstructured":"Benoit L, Zerbib J, Koual M et al (2021) What can we learn from the 10 mm lymph node size cut-off on the CT in advanced ovarian cancer at the time of interval debulking surgery? Gynecol Oncol 162(3):667\u2013673","journal-title":"Gynecol Oncol"},{"issue":"6","key":"2734_CR28","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2018.29.e98","volume":"29","author":"S Han","year":"2018","unstructured":"Han S, Woo S, Suh CH et al (2018) Performance of pre-treatment 1\u2078F-fluorodeoxyglucose positron emission tomography\/computed tomography for detecting metastasis in ovarian cancer: a systematic review and meta-analysis. J Gynecol Oncol 29(6):e98","journal-title":"J Gynecol Oncol"},{"key":"2734_CR29","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/jnci\/dji102","volume":"97","author":"PB Panici","year":"2005","unstructured":"Panici PB, Maggioni A, Hacker N et al (2005) Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst 97:560\u2013566","journal-title":"J Natl Cancer Inst"},{"key":"2734_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1200\/JCO.2024.42.17_suppl.LBA5505","volume":"42","author":"JM Classe","year":"2024","unstructured":"Classe JM, Campion L, Lecuru F et al (2024) Omission of lymphadenectomy in patients with advanced epithelial ovarian cancer treated with primary or interval cytoreductive surgery after neoadjuvant chemotherapy: the CARACO phase III randomized trial. J Clin Oncol 42:17","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-025-02734-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-025-02734-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-025-02734-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T06:04:17Z","timestamp":1745301857000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-025-02734-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["2734"],"URL":"https:\/\/doi.org\/10.1007\/s10147-025-02734-0","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]},"assertion":[{"value":"23 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}